BackCardio Diagnostics Holdings Overview

Cardio Diagnostics Holdings EBIT

Latest ebit for CDIO: $-63K, above the sector sector average of $-9.6M.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$1.50M
↑ 15.26% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

-$63.12K
↑ 99% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Cardio Diagnostics Holdings (CDIO) FAQ

As of the most recent data (June 2026), CDIO shows a EBIT of $-63K. That compares with $-6.3M in the prior-year period — up 99.0% year over year. That is above the sector sector average of $-9.6M. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CDIO's EBIT is now $-63K (was $-6.3M) — a 99.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Cardio Diagnostics Holdings is outperforming or lagging.

The its sector sector average EBIT is about $-9.6M. Cardio Diagnostics Holdings is at $-63K, which is higher that average. That is roughly 99.3% above the sector mean. Use the comparison chart on this page to see how CDIO stacks up against individual peers as well.

Tracking CDIO's ebit over time shows whether Cardio Diagnostics Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $-63K That compares with $-6.3M in the prior-year period — up 99.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Cardio Diagnostics Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-63K) with ownership activity and broader fundamentals.